BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26186453)

  • 1. Comparison of Clinical Characteristic and Prognosis between Ovarian Clear Cell Carcinoma and Serous Carcinoma: A 10-Year Cohort Study of Chinese Patients.
    Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
    PLoS One; 2015; 10(7):e0133498. PubMed ID: 26186453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study.
    Ku FC; Wu RC; Yang LY; Tang YH; Chang WY; Yang JE; Wang CC; Jung SM; Lin CT; Chang TC; Chao A; Lai CH
    J Formos Med Assoc; 2018 Feb; 117(2):117-125. PubMed ID: 28389144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.
    Ye S; You Y; Yang J; Cao D; Bai H; Huang H; Wu M; Chen J; Lang J; Shen K
    Int J Gynecol Cancer; 2014 Nov; 24(9):1590-6. PubMed ID: 25254564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
    Matsuura T; Otsuka I; Ouchi T; Ouchi E; Asano R; Miyasaka N
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Oliver KE; Brady WE; Birrer M; Gershenson DM; Fleming G; Copeland LJ; Tewari K; Argenta PA; Mannel RS; Secord AA; Stephan JM; Mutch DG; Stehman FB; Muggia FM; Rose PG; Armstrong DK; Bookman MA; Burger RA; Farley JH
    Gynecol Oncol; 2017 Nov; 147(2):243-249. PubMed ID: 28807367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.
    Sugiyama T; Kamura T; Kigawa J; Terakawa N; Kikuchi Y; Kita T; Suzuki M; Sato I; Taguchi K
    Cancer; 2000 Jun; 88(11):2584-9. PubMed ID: 10861437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.
    Raffone A; Travaglino A; Raimondo D; Maletta M; De Vivo V; Visiello U; Casadio P; Seracchioli R; Zullo F; Insabato L; Mollo A
    Int J Gynaecol Obstet; 2022 Sep; 158(3):520-527. PubMed ID: 34797919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.
    Lee YY; Kim TJ; Kim MJ; Kim HJ; Song T; Kim MK; Choi CH; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Sep; 122(3):541-7. PubMed ID: 21640372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
    Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG
    Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type.
    Goto T; Takano M; Aoyama T; Miyamoto M; Watanabe A; Kato M; Sasaki N; Hirata J; Sasa H; Furuya K
    Eur J Gynaecol Oncol; 2012; 33(6):579-83. PubMed ID: 23327049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial.
    Timmers PJ; Zwinderman AH; Teodorovic I; Vergote I; Trimbos JB
    Int J Gynecol Cancer; 2009 Jan; 19(1):88-93. PubMed ID: 19258948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.
    Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB
    Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study.
    Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
    Int J Gynecol Cancer; 2009 Nov; 19(8):1353-7. PubMed ID: 20009889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma.
    Takasaki K; Miyamoto M; Takano M; Soyama H; Aoyama T; Matsuura H; Iwahashi H; Ishibashi H; Sakamoto T; Furuya K
    Int J Clin Oncol; 2019 Oct; 24(10):1273-1283. PubMed ID: 31073813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology-A Comparative Study.
    Schnack TH; Høgdall E; Nedergaard L; Høgdall C
    Int J Gynecol Cancer; 2016 Jan; 26(1):82-90. PubMed ID: 26569060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.
    Zhu J; Wen H; Bi R; Wu Y; Wu X
    J Gynecol Oncol; 2017 Nov; 28(6):e77. PubMed ID: 29027395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
    J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Ju UC; Kang WD; Kim SM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China.
    Ye S; Yang J; You Y; Cao D; Bai H; Lang J; Chen J; Shen K
    Fertil Steril; 2014 Dec; 102(6):1656-62. PubMed ID: 25256925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.